SMTL ID : 5qtu.1

FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

hetero-1-1-mer

Ligands

1 x QEV: methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate(Non-covalent)

QEV.1: 26 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.134, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: EDO.9, EDO.10 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.28, A:Y.134, A:I.141, A:A.183, A:K.185, A:T.206 Hydrogen bonds: A:R.26, A:H.27, A:L.28, A:K.185, A:G.186, A:D.187, A:S.188, A:S.188 Water bridges: A:K.185, A:G.209

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: K.160, R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177

9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 5 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 EDO.4: 2 residues within 4Å: Chain A: R.9, L.62 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.9 EDO.5: 8 residues within 4Å: Chain A: R.9, G.10, E.11, W.12, P.13, I.61, L.62, L.145 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.10, A:W.12, A:W.12 Water bridges: A:I.61 EDO.6: 4 residues within 4Å: Chain A: K.185, G.209, E.210, G.211 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.185, A:G.209, A:G.211 EDO.7: 3 residues within 4Å: Chain A: T.168, H.169 Ligands: EDO.8 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.169 EDO.8: 7 residues within 4Å: Chain A: S.90, G.91, Y.92, T.168, K.170, M.171 Ligands: EDO.7 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.90, A:Y.92, A:T.168 Water bridges: A:Y.92 EDO.9: 6 residues within 4Å: Chain A: H.44, A.88, S.207, W.208 Ligands: QEV.1, EDO.11 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.207 Water bridges: A:G.209 EDO.10: 1 residues within 4Å: Ligands: QEV.1 No protein-ligand interaction detected (PLIP) EDO.11: 6 residues within 4Å: Chain A: H.44, Y.85, M.87, A.88, E.89 Ligands: EDO.9 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Y.85, A:A.88, A:E.89, A:E.89, A:E.89 Water bridges: A:Y.85

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Corte, J.R. et al., Potent, Orally Bioavailable and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups. J.Med.Chem. (2019)

Release Date

2019-12-25

Peptides

Coagulation factor XI: A
Coagulation factor XI: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

Coagulation factor XI

Coagulation factor XI

Related Entries With Identical Sequence